Showing results (1711-1720 of 3,268) with videos related to

Sort By:
Pageof 327
Radiation Protection Dosimetry|October 18, 2002
Development of a gamma ray monitor using a CdZnTe semiconductor detectorA H D Rasolonjatovo, T Shiomi, T Nakamura, et al.
Annals of Nuclear Medicine|July 20, 2002
A case of gastric duplication evaluated by gastric emptying scintigraphySusumu Shiomi, Yasuhiro Fujiwara, Etsushi Kawamura, et al.
Cardiovascular Intervention and Therapeutics|May 25, 2012
Comparison of 3-year clinical outcomes after transradial versus transfemoral percutaneous coronary interventionMasahiro Natsuaki, Takeshi Morimoto, Yutaka Furukawa, et al.
Archives of Biochemistry and Biophysics|April 10, 2012
Metabolomic analysis to discover candidate therapeutic agents against acute pancreatitisAya Sakai, Shin Nishiumi, Yuuki Shiomi, et al.
Annals of Nuclear Medicine|September 8, 2001
A case of glucagonoma with high uptake on F-18 fluorodeoxyglucose positron emission tomographyS Nishiguchi, S Shiomi, H Ishizu, et al.
The Journal of Antibiotics|August 31, 2000
Argifin, a new chitinase inhibitor, produced by Gliocladium sp. FTD-0668. I. Taxonomy, fermentation, and biological activitiesS Omura, N Arai, Y Yamaguchi, et al.
The FEBS Journal|July 28, 2005
Myocyte enhancer factor 2 (MEF2) is a key modulator of the expression of the prothoracicotropic hormone gene in the silkworm, Bombyx moriKunihiro Shiomi, Yoshihiro Fujiwara, Tsutomu Atsumi, et al.
Journal of Gastroenterology and Hepatology|March 1, 1994
Relationship between endotoxin antibody levels and portal systemic shunt evaluated by per-rectal portal scintigraphyS Shiomi, T Kuroki, T Ueda, et al.
The Journal of Antibiotics|November 1, 1993
A new antibiotic, cypemycin. Taxonomy, fermentation, isolation and biological characteristicsK Komiyama, K Otoguro, T Segawa, et al.
The American Journal of Cardiology|August 16, 2014
Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2)Akira Marui, Takeshi Kimura, Noboru Nishiwaki, et al.
Pageof 327